[1]
WHO. Coronavirus disease 2019 (COVID-19) Situation Report – 57 2019.Available from:. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200317-sitrep-57-covid-19.pdf?sfvrsn=a26922f2_2
[2]
Wenham, C.; Smith, J.; Morgan, R. Gender and COVID-19 Working Group. COVID-19: the gendered impacts of the outbreak. Lancet, 2020, 395(10227), 846-848.
[http://dx.doi.org/10.1016/S0140-6736(20)30526-2] [PMID: 32151325]
[http://dx.doi.org/10.1016/S0140-6736(20)30526-2] [PMID: 32151325]
[3]
Chan, J.F.; Yip, C.C.; To, K.K.; Tang, T.H.; Wong, S.C.; Leung, K.H.; Fung, A.Y.; Ng, A.C.; Zou, Z.; Tsoi, H.W.; Choi, G.K. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J. Clin. Microbiol., 2020, 58(5), e00310-20.
[http://dx.doi.org/10.1128/JCM.00310-20] [PMID: 32132196]
[http://dx.doi.org/10.1128/JCM.00310-20] [PMID: 32132196]
[4]
Cui, J.; Li, F.; Shi, Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol., 2019, 17(3), 181-192.
[http://dx.doi.org/10.1038/s41579-018-0118-9] [PMID: 30531947]
[http://dx.doi.org/10.1038/s41579-018-0118-9] [PMID: 30531947]
[5]
Li, Y.; Xia, L. Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. AJR Am. J. Roentgenol., 2020, 214(6), 1280-1286.
[http://dx.doi.org/10.2214/AJR.20.22954] [PMID: 32130038]
[http://dx.doi.org/10.2214/AJR.20.22954] [PMID: 32130038]
[6]
Ai, T.; Yang, Z.; Hou, H.; Zhan, C.; Chen, C.; Lv, W.; Tao, Q.; Sun, Z.; Xia, L. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology, 2020, 26, 200642
[http://dx.doi.org/10.1148/radiol.2020200642] [PMID: 32101510]
[http://dx.doi.org/10.1148/radiol.2020200642] [PMID: 32101510]
[7]
Pan, F.; Ye, T.; Sun, P.; Gui, S.; Liang, B.; Li, L.; Zheng, D.; Wang, J.; Hesketh, R.L.; Yang, L.; Zheng, C. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology, 2020, 13, 200370
[http://dx.doi.org/10.1148/radiol.2020200370] [PMID: 32053470]
[http://dx.doi.org/10.1148/radiol.2020200370] [PMID: 32053470]
[8]
Xiang, J.; Yan, M.; Li, H.; Liu, T.; Lin, C.; Huang, S.; Shen, C. Evaluation of Enzyme-Linked Immunoassay and Colloidal Gold-
Immunochromatographic Assay Kit for Detection of Novel Coronavirus (SARS-Cov-2) Causing an Outbreak of Pneumonia (COVID-19). medRxiv, 2020.
[9]
Cai, X.; Chen, J.; Hu, J.; Long, Q.; Deng, H.; Fan, K.; Liao, P.; Liu, B.; Wu, G.; Chen, Y.; Li, Z. A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Corona Virus Disease 2019 (COVID-19). medRxiv, 2020.
[10]
Corman, V.; Bleicker, T.; Brünink, S.; Drosten, C.; Zambon, M. Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR 2020.Available from:. https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf
[11]
World Health Organization. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance. 2020.(Accessed on March 2nd, 2020).
[12]
Lucia, C.; Federico, P.B.; Alejandra, G.C. An ultrasensitive, rapid, and portable coronavirus SARS-CoV-2 sequence detection method based on CRISPR-Cas12. bioRxiv, 2020.
[http://dx.doi.org/10.1101/2020.02.29.971127]
[http://dx.doi.org/10.1101/2020.02.29.971127]
[13]
Yan, G.; Lee, C.K.; Lam, L.T.M.; Yan, B.; Chua, Y.X.; Lim, A.Y.N.; Phang, K.F.; Kew, G.S.; Teng, H.; Ngai, C.H.; Lin, L.; Foo, R.M.; Pada, S.; Ng, L.C.; Tambyah, P.A. Covert COVID-19 and false-positive dengue serology in Singapore. Lancet Infect. Dis., 2020, 20(5), 536.
[http://dx.doi.org/10.1016/S1473-3099(20)30158-4] [PMID: 32145189]
[http://dx.doi.org/10.1016/S1473-3099(20)30158-4] [PMID: 32145189]
[14]
Li, G.; De Clercq, E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat. Rev. Drug Discov., 2020, 19(3), 149-150.
[http://dx.doi.org/10.1038/d41573-020-00016-0] [PMID: 32127666]
[http://dx.doi.org/10.1038/d41573-020-00016-0] [PMID: 32127666]
[15]
Agostini, M.L.; Andres, E.L.; Sims, A.C.; Graham, R.L.; Sheahan, T.P.; Lu, X.; Smith, E.C.; Case, J.B.; Feng, J.Y.; Jordan, R.; Ray, A.S.; Cihlar, T.; Siegel, D.; Mackman, R.L.; Clarke, M.O.; Baric, R.S.; Denison, M.R. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonucle-ase. MBio, 2018, 9(2), e00221-e18.
[http://dx.doi.org/10.1128/mBio.00221-18] [PMID: 29511076]
[http://dx.doi.org/10.1128/mBio.00221-18] [PMID: 29511076]
[16]
de Wit, E.; Feldmann, F.; Cronin, J.; Jordan, R.; Okumura, A.; Thomas, T.; Scott, D.; Cihlar, T.; Feldmann, H. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc. Natl. Acad. Sci. USA, 2020, 117(12), 6771-6776.
[http://dx.doi.org/10.1073/pnas.1922083117] [PMID: 32054787]
[http://dx.doi.org/10.1073/pnas.1922083117] [PMID: 32054787]
[17]
Wrapp, D.; Wang, N.; Corbett, K.S.; Goldsmith, J.A.; Hsieh, C.L.; Abiona, O.; Graham, B.S.; McLellan, J.S. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 2020, 367(6483), 1260-1263.
[http://dx.doi.org/10.1126/science.abb2507] [PMID: 32075877]
[http://dx.doi.org/10.1126/science.abb2507] [PMID: 32075877]
[18]
Hoffmann, M.; Kleine-Weber, H.; Schroeder, S.; Krüger, N.; Herrler, T.; Erichsen, S.; Schiergens, T.S.; Herrler, G.; Wu, N.H.; Nitsche, A.; Müller, M.A.; Drosten, C.; Pöhlmann, S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven Protease Inhibitor. Cell, 2020, 181(2), 271-280.e8.
[http://dx.doi.org/10.1016/j.cell.2020.02.052] [PMID: 32142651]
[http://dx.doi.org/10.1016/j.cell.2020.02.052] [PMID: 32142651]
[19]
Beck, B.R.; Shin, B.; Choi, Y.; Park, S.; Kang, K. Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model. bioRxiv, 2020.
[http://dx.doi.org/10.1101/2020.01.31.929547]
[http://dx.doi.org/10.1101/2020.01.31.929547]
[20]
Zhou, Y.; Hou, Y.; Shen, J.; Huang, Y.; Martin, W.; Cheng, F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov., 2020, 6(1), 14.
[http://dx.doi.org/10.1038/s41421-020-0153-3] [PMID: 32194980]
[http://dx.doi.org/10.1038/s41421-020-0153-3] [PMID: 32194980]
[21]
Zhang, H.; Saravanan, K.M.; Yang, Y.; Hossain, M.T.; Li, J.; Ren, X.; Wei, Y. Deep learning based drug screening for novel coronavirus 2019-nCov 2020.